Xeris Pharmaceuticals, Inc. Gains 29.24%
Mon, May 16, 2022 at 05:30 PM
Xeris Pharmaceuticals, Inc. (XERS:NASDAQ) soared at $2.21, a gain of 29.2%. The stock appeared on our News Catalysts scanner on Thu, May 12, 2022 at 04:47 PM in the 'BIOTECH' category. From Mon, May 02, 2022, the stock recorded 11.11% Up Days and 30.00% Green Days
The stock spiked on Fri, Mar 18, 2022 at $2.95 with a volume of 2M+.
About Xeris Pharmaceuticals, Inc. (XERS:NASDAQ)
Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.
Top 10 Gainers:
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 65.87%
- New Age Beverages Corporation (NBEV:NASDAQ), 65.82%
- Trevena, Inc. (TRVN:NASDAQ), 49.16%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 38.96%
- Xeris Pharmaceuticals, Inc. (XERS:NASDAQ), 29.24%
- Aspira Women's Health Inc. (AWH:NASDAQ), 28.57%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 27.1%
- High Tide Inc. (HITI:NASDAQ), 26.67%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 26.47%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 24.75%